National Cancer Prevention Center

National Cancer Prevention Center

The German Cancer Research Center (DKFZ) and the German Cancer Aid are planning a National Cancer Prevention Center with a building in Heidelberg.

The National Cancer Prevention Center brings together cancer prevention research, an outpatient prevention clinic- also open to participants in ongoing prevention studies, and a Citizens' Information Center. With support from our network of partners, experts will develop evidence-based programs for personalized cancer risk prevention and design campaigns to increase prevention awareness across the country. In addition, new individualized digital cancer prevention systems are to be developed , for example in the form of an App, as well as systems to support prevention research. The DKFZ plans to recruit a working group specifically in the area of "Digital Cancer Prevention" later this year, not least because the extensive range of DKFZ translational prevention research is being consolidated into the National Cancer Prevention Center, with German Cancer Aid funding the project with 25 million euros.

The new strategic partnership between DKFZ and Deutsche Krebshilfe aims to further exploit the great potential in cancer prevention. To launch this cooperation, the DKFZ and the German Cancer Aid inaugurated the 1st National Cancer Prevention Week from 10 to 13 September 2019 under the motto "Prevention is possible, Neighbor! Active against cancer.'

A further "National Cancer Prevention Week" is planned for mid-September 2020. This will happen in conjunction with the second "Cancer Prevention" conference in combination with the PROBASE Symposium which will be held in Heidelberg on 17 and 18 September.

Since its foundation, cancer prevention has been one of the main focuses of the DKFZ. Researchers are currently active in many areas of cancer prevention and prevention research:

  • They promote measures to reduce tobacco consumption and build awareness of the health risks associated with tobacco consumption and nicotine products.
  • They are examining how diet is associated with increased cancer risks in large population-based studies.
  • They determine the influence of alcohol consumption on cancer risk and cancer mortality.
  • They are exploring how sport and physical activity can reduce cancer risk and improve the effectiveness of cancer therapies.
  • They are examining the influence of obesity on cancer risk and cancer mortality.
  • They are exploring the impact of hormone replacement therapy on cancer risk.
  • They are developing vaccines against carcinogenic viruses and promoting those vaccines already approved.
  • They are searching for as yet unknown carcinogens and developing measures to protect people from infection with these pathogens.
  • They are developing measures to improve colorectal cancer screening and to motivate more people to participate in screening tests.
  • They identify genetic risk markers to better assess hereditary cancer risks and to initiate tightly-meshed early detection measures.
  • They are looking for biomarkers that point to cancer as early as possible, so that there is a good chance of treating the disease.
  • They investigate how chronic inflammatory reactions promote cancer and what can be done to prevent this.

to top